ciprofloxacin has been researched along with nystatin a1 in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.13) | 18.2507 |
| 2000's | 2 (5.13) | 29.6817 |
| 2010's | 33 (84.62) | 24.3611 |
| 2020's | 2 (5.13) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chudík, S; Cvacka, J; Dvorská, M; Holubová, P; Julínek, O; Kloucek, P; Kokoska, L; Marek, R; Slapetová, T; Smejkal, K; Urbanová, M; Zima, A | 1 |
| Abdullah, ST; Ahmed, SK; Azeeza, S; Kamal, A; Khan, IA; Reddy, AM; Sharma, S; Shetti, RV; Swapna, P | 1 |
| Gadakh, AV; Karale, BK; Pandit, C; Rindhe, SS | 1 |
| Haveliwala, DD; Kamdar, NR; Mistry, PT; Patel, SK | 1 |
| Mali, MD; Patel, MM; Patel, SK | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Makawana, JA; Mungra, DC; Patel, MP; Patel, RG | 1 |
| Akhaja, TN; Raval, JP | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
| Bobade, VD; Gaikwad, ND; Patil, SV | 1 |
| Patel, MP; Patel, RG; Shah, NM | 1 |
| Bonifácio, VD; Gawande, MB; Mhaske, GR; Shelke, SN | 1 |
| Parmar, BD; Parmar, NJ; Patel, RA; Talpada, NP | 1 |
| Kathrotiya, HG; Patel, MP | 1 |
| Kanawade, SB; Rajani, DP; Toche, RB | 1 |
| Jardosh, HH; Patel, MP | 1 |
| Kalaria, PN; Raval, DK; Satasia, SP | 1 |
| Karad, SC; Purohit, VB; Raval, DK | 1 |
| Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Pathak, P; Sagar, R; Tiwari, S | 1 |
| Helaly, SE; Hyde, KD; Richter, C; Stadler, M; Thongbai, B | 1 |
| Ajay Kumar, K; Kameshwar, VH; Raghavendra, KR; Renuka, N; Shashikanth, S; Srinivasan, B | 1 |
| Kamani, RD; Karad, SC; Purohit, VB; Raval, DK; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P; Thummar, RP; Vaghasiya, BK | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakor, P | 1 |
| Achutha, DK; Kariyappa, AK; Krishnappagowda, LN; Lokeshwari, DM; Shivalingegowda, N; Srinivasan, B | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P | 1 |
| Sandargo, B; Stadler, M; Surup, F; Thongbai, B | 1 |
| Abraham, WR; Chepkirui, C; Decock, C; Matasyoh, JC; Stadler, M; Wanga, LA; Yuyama, KT | 1 |
| Biggs, J; Brumley, D; Gunasekera, SP; Luesch, H; Paul, VJ; Sauvage, T; Spencer, KA | 1 |
| Akhtar, W; Akhter, M; Alam, MM; Khan, MF; Nainwal, LM; Parvez, S; Shaquiquzzaman, M; Tasneem, S; Verma, G | 1 |
| Cheng, T; Chepkirui, C; Decock, C; Matasyoh, JC; Stadler, M | 1 |
| Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
| Bode, ML; Coyanis, EM; Harrison, AT; Mosebi, S; Rashamuse, TJ; van Vuuren, S | 1 |
| Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
| Boyce, ST; Holder, IA; Warden, GD | 1 |
| Boyce, ST; Holder, IA | 1 |
3 review(s) available for ciprofloxacin and nystatin a1
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Green recipes to quinoline: A review.
Topics: Drug Design; Green Chemistry Technology; Humans; Quinolines | 2019 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
36 other study(ies) available for ciprofloxacin and nystatin a1
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Antibacterial C-geranylflavonoids from Paulownia tomentosa Fruits.
Topics: Anti-Bacterial Agents; Bacteria; Candida albicans; Circular Dichroism; Czech Republic; Flavonoids; Fruit; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Scrophulariaceae | 2008 |
Anti-tubercular agents. Part 5: synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congeners.
Topics: Animals; Antitubercular Agents; Bacteria; Benzothiadiazines; Cell Line; Cell Survival; Female; Fungi; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2010 |
Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacillus subtilis; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Escherichia coli; Fluorine; Humans; Microbial Sensitivity Tests; Oxazoles; Pseudomonas aeruginosa; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2010 |
Design, synthesis and in vitro evaluation of antitubercular and antimicrobial activity of some novel pyranopyrimidines.
Topics: Anti-Infective Agents; Aspergillus niger; Bacteria; Drug Design; Drug Evaluation, Preclinical; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyrimidines | 2010 |
Bernthsen synthesis, antimicrobial activities and cytotoxicity of acridine derivatives.
Topics: Acridines; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Aspergillus niger; Bacteria; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Microwave assisted synthesis and antimicrobial evaluation of new fused pyran derivatives bearing 2-morpholinoquinoline nucleus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Candida albicans; Fungi; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microwaves; Mycoses; Pyrans; Quinolines | 2011 |
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
Topics: Antifungal Agents; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Fungi; Indoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
Hybrids of ravuconazole: synthesis and biological evaluation.
Topics: Anti-Infective Agents; Aspergillus niger; Bacteria; Candida albicans; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2012 |
New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
Topics: Antimalarials; Antitubercular Agents; Chemistry Techniques, Synthetic; Electrons; Fungi; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines | 2012 |
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Green Chemistry Technology; Halogenation; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Pyrazoles; Tuberculosis | 2012 |
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
Topics: Aldehydes; Anti-Bacterial Agents; Coumarins; Gram-Negative Bacteria; Gram-Positive Bacteria; Heterocyclic Compounds; Ionic Liquids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrans; Pyrazolones; Quinolines; Structure-Activity Relationship | 2013 |
Synthesis and identification of β-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents.
Topics: Animals; Anti-Infective Agents; Antioxidants; Antitubercular Agents; Artemia; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluorine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Mycobacterium tuberculosis; Ovum; Quinolines; Structure-Activity Relationship | 2013 |
Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzoxazines; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Structure-Activity Relationship | 2013 |
Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Artemia; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Motor Activity; Quinolones; Structure-Activity Relationship; Tuberculosis | 2013 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Efficient synthesis of new 2,3-dihydrooxazole-spirooxindoles hybrids as antimicrobial agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Oxazoles; Spiro Compounds; Structure-Activity Relationship | 2016 |
Pyristriatins A and B: Pyridino-Cyathane Antibiotics from the Basidiomycete Cyathus cf. striatus.
Topics: Anti-Bacterial Agents; Basidiomycota; Cyathus; Diterpenes; Macrophages; Molecular Structure; Thailand | 2016 |
Synthesis of lignan conjugates via cyclopropanation: Antimicrobial and antioxidant studies.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Bacteria; Cyclopropanes; Dose-Response Relationship, Drug; Fungi; Lignans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2016 |
Synthesis and biological screening of novel 2-morpholinoquinoline nucleus clubbed with 1,2,4-oxadiazole motifs.
Topics: Anti-Infective Agents; Bacteria; Bacterial Proteins; Catalytic Domain; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Fungi; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2017 |
1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
Topics: Anti-Infective Agents; Antimalarials; Folic Acid Antagonists; Molecular Docking Simulation; Oxadiazoles; Spectrum Analysis; Triazoles | 2017 |
Synthesis of novel 2-pyrazoline analogues with potent anti-inflammatory effect mediated by inhibition of phospholipase A2: Crystallographic, in silico docking and QSAR analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Phospholipase A2 Inhibitors; Phospholipases A2; Pyrazoles; Quantitative Structure-Activity Relationship | 2017 |
Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Benzothiazoles; Cell Survival; Computer Simulation; Dose-Response Relationship, Drug; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Quantum Theory; Schizosaccharomyces; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2017 |
Cysteine-Derived Pleurotin Congeners from the Nematode-Trapping Basidiomycete Hohenbuehelia grisea.
Topics: Acetylcysteine; Agaricales; Animals; Anti-Infective Agents; Basidiomycota; Cysteine; Fungi; Heterocyclic Compounds, 4 or More Rings; Magnetic Resonance Spectroscopy; Nematoda; Sulfhydryl Compounds; Sulfur; Thailand | 2018 |
Microporenic Acids A-G, Biofilm Inhibitors, and Antimicrobial Agents from the Basidiomycete Microporus Species.
Topics: Animals; Anti-Infective Agents; Basidiomycota; Biofilms; Candida albicans; Cell Line; Cell Line, Tumor; Gram-Positive Bacteria; HeLa Cells; Humans; Kenya; Mice; Microbial Sensitivity Tests; Staphylococcus aureus | 2018 |
Isolation and Characterization of Anaephenes A-C, Alkylphenols from a Filamentous Cyanobacterium ( Hormoscilla sp., Oscillatoriales).
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacillus cereus; Cell Survival; Cyanobacteria; HCT116 Cells; Humans; Molecular Structure; Phenols; Spectrum Analysis; Staphylococcus aureus | 2018 |
Sesquiterpenes from an Eastern African Medicinal Mushroom Belonging to the Genus Sanghuangporus.
Topics: Africa, Eastern; Agaricales; Anti-Infective Agents; Antibiotics, Antineoplastic; Bacteria; Basidiomycota; Cell Line, Tumor; Drug Screening Assays, Antitumor; Fermentation; Fungi; Humans; Kenya; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Sesquiterpenes; Tandem Mass Spectrometry | 2019 |
Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens.
Topics: Adaptor Proteins, Signal Transducing; Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Oxazoles; Structure-Activity Relationship; Transcription Factors | 2020 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes.
Topics: Administration, Topical; Amphotericin B; Burns; Candida; Cells, Cultured; Ciprofloxacin; Culture Techniques; Drug Therapy, Combination; Enterobacteriaceae; Fibroblasts; Humans; Keratinocytes; Microbial Sensitivity Tests; Norfloxacin; Nystatin; Skin; Skin, Artificial; Staphylococcus aureus | 1995 |
Formulation of 'idealized' topical antimicrobial mixtures for use with cultured skin grafts.
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Candida; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Mupirocin; Neomycin; Nystatin; Polymyxin B; Pseudomonas aeruginosa; Skin; Skin Transplantation; Staphylococcus aureus | 1996 |